The Management Board of Biofrontera AG maintains its guidance for fiscal year 2021 published on April 12, 2021 in its entirety. Accordingly, the Management Board expects annual revenues between EUR 25 million and 32 million and EBIT loss between EUR 13 million and EUR 16 million.